BLFS 8-K 2026-10-06

BIOLIFE SOLUTIONS INC (BLFS) 8-K dated 2026-10-06 — accession 0001193125-26-415012. This URL is the filing, not the BLFS hub.

BIOLIFE SOLUTIONS INC (BLFS) is a medical instruments & supplies company listed on US.

BIOLIFE SOLUTIONS INC filed a 8-K on 2026-10-06. Accession 0001193125-26-415012.

Cached items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BLFS revenue for 2025-12-31 was $96.2M. Net income was -$4.6M. Revenue was down 32.8% from 2023-12-31 to 2025-12-31. BLFS currently screens at market cap $1.05B.

Not investment advice. The BLFS SEC hub lists recent forms. The stock page is the research view.